Telomere structure and telomerase in health and disease (Review)

International Journal of Oncology

Volumn 41, Issue 5, 2012, Pages 1561-1569

  Gomez, Daniel E ^a   Armando, Romina G ^a   Farina, Hernán G ^a   Menna, Pablo Lorenzano ^a   Cerrudo, Carolina S ^a   Ghiringhelli, P Daniel ^a   Alonso, Daniel F ^a  

^a UNIVERSIDAD NACIONAL DE QUILMES   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

DOUBLE STRANDED DNA; ORIGIN RECOGNITION COMPLEX; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; RAD50 PROTEIN; RAD51 PROTEIN; RECQ HELICASE; TANKYRASE; TELOMERASE; TELOMERIC REPEAT BINDING FACTOR 1; TELOMERIC REPEAT BINDING FACTOR 2;

AMINO TERMINAL SEQUENCE; APLASTIC ANEMIA; APOPTOSIS; BIOTRANSFORMATION; CARBOXY TERMINAL SEQUENCE; CELL CYCLE ARREST; CELL IMMORTALIZATION; CHROMOSOME 11; CHROMOSOME 17; CHROMOSOME 2; CHROMOSOME ANALYSIS; DEGENERATIVE DISEASE; DIMERIZATION; DISEASE ASSOCIATION; DNA REPLICATION; FIBROSING ALVEOLITIS; HOMOLOGOUS RECOMBINATION; HUMAN; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; PREDICTIVE VALUE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; PROTEIN TARGETING; QUANTITATIVE ANALYSIS; REVIEW; SEQUENCE ANALYSIS; SIGNAL TRANSDUCTION; STRUCTURE ACTIVITY RELATION; STRUCTURE ANALYSIS; TELOMERE;

ANIMALS; CELL TRANSFORMATION, NEOPLASTIC; HUMANS; MAMMALS; NEOPLASMS; TELOMERASE; TELOMERE; TELOMERE HOMEOSTASIS;

EID: 84867808311     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2012.1611     Document Type: Review

References (95)

1. Muller HJ: The remaking of chromosomes. The Collecting Net 13: 181-198, 1938.
2. McClintock B: The stability of broken ends of chromosomes in Zea mays. Genetics 26: 234-282, 1941.
3. Blackburn EH and Gall JG: A tandemly repeated sequence at the termini of the extrachromosomal ribosomal RNA genes in Tetrahymena. J Mol Biol 120: 22-53, 1978.
4. Blackburn EH: Telomeres: no end in sight. Cell 77: 621-623, 1994.
5. Sandell LL and Zakian VA: Loss of a yeast telomere: arrest, recovery, and chromosome loss. Cell 75: 729-739, 1993. (Pubitemid 23346371)
6. Greider CW and Blackburn EH: Identification of a specific telomere terminal transferase activity in Tetrahymena extracts. Cell 43: 405-413, 1985. (Pubitemid 16213265)
7. Meyne J, Ratliff RL and Moyzis RK: Conservation of the human telomere sequence (TTAGGG)n among vertebrates. Proc Natl Acad Sci USA 86: 7049-7053, 1989. (Pubitemid 19240864)
8. Lejnine S, Makarov VL and Langmore JP: Conserved nucleo protein structure at the ends of vertebrate and invertebrate chromosomes. Proc Natl Acad Sci USA 92: 2393-2397, 1995.
9. Wright WE, Tesmer VM, Huffman KE, Levene SD and Shay JW: Normal human chromosomes have long G-rich telomeric overhangs at one end. Genes Dev 11: 2801-2809, 1997. (Pubitemid 27481681)
10. Zvereva MI, Shcherbakova DM and Dontsova OA: Telomerase: structure, functions, and activity regulation. Biochemistry 75: 1563-1583, 2010.
11. Hänsel R, Löhr F, Foldynová-Trantírková S, Bamberg E, Trantírek L and Dötsch V: The parallel G-quadruplex structure of vertebrate telomeric repeat sequences is not the preferred folding topology under physiological conditions. Nucleic Acids Res 390: 5768-5775, 2011.
12. Wyatt HDM, West SC and BeattieTL: InTERTpreting telomerase structure and function. Nucleic Acids Res 38: 5609-5612, 2010.
13. Linger BR and Price CM: Conservation of telomere protein complexes: shuffling though evolution. Crit Rev Biochem Mol Biol 44: 434-446, 2009.
14. Palm W and de Lange T: How shelterin protects mammalian telomeres. Annu Rev Genet 42: 301-334, 2008.
15. Martinez P and Blasco MA: Telomeric and extra-telomeric roles for telomerase and the telomere-binding proteins. Nat Rev Cancer 11: 161-176, 2011.
16. Chong L, van Steensel B, Broccoli D, Erdjument-Bromage H, Hanish J, Tempst P and de Lange T: A human telomeric protein. Science 270: 1663-1667, 1995. (Pubitemid 26002442)
17. Bianchi A and de Lange T: Ku binds telomeric DNA in vitro. J Biol Chem 274: 21223-21227, 1999.
18. Smogorzewska A, van Steensel B, Bianchi A, Oelmann S, Schefer MR, Schnapp G and de Lange T: Control of human telomere length by TRF1 and TRF2. Mol Cell Biol 20: 1659-1668, 2000. (Pubitemid 30100185)
19. van Steensel B and de Lange T: Control of telomere length by the human telomeric protein TRF1. Nature 385: 740-743, 1997.
20. van Stensel B, Smogorzewska A and de Lange T: TRF2 protects human telomeres from end to end fusions. Cell 92: 401-413, 1998. (Pubitemid 28093017)
21. Karlseder J, Broccoli D, Dai Y, Hardy S and de Lange T: p53- and ATM-dependent apoptosis induced by telomerase lacking TRF2. Science 283: 1321-1325, 1999.
22. Griffith JD, Comeau L, Rosenfield S, Stansel RM, Banchi A, Moss H and de Lange T: Mammalian telomeres end in a large duplex loop. Cell 97: 503-514, 1999. (Pubitemid 29231173)
23. Herbig U, Jobling WA, Chen BP, Chen DJ and Sedivy JM: Telomere shortening triggers senescence of human cells through a pathway involving ATM, p53 and p21 (CIP1), but not p16(INK4a). Mol Cell 14: 501-513, 2004. (Pubitemid 38648803)
24. Gong Y and de Lange TA: Shd1-controlled POT1a provides support for repression of ATR signaling at telomeres through RPA exclusion. Mol Cell 40: 377-387, 2010.
25. Lee CC and Huang TS: A novel topoisomerase II poison GL331 preferentially induces DNA cleavage at (C/G)T sites and can cause telomere DNA damage. Pharm Res 18: 846-851, 2001.
26. Martinez P, Thanasoula M, Carlos AR, et al: Mammalian Rap1 controls telomere function and gene expression through binding to telomeric and extratelomeric sites. Nat Cell Biol 8: 768-780, 2010.
27. Buchman AR, Kimmerly WJ, Rine J and Kornberg RD: Two DNA-binding factors recognize specific sequences at silencers, upstream activating sequences, autonomously replicating sequences and telomeres in Saccharomyces cerevisiae. Mol Cell Biol 8: 210-225, 1988.
28. Teo H, Ghosh S, Luesch H, et al: Telomere-independent Rap1 is an IKK adaptor and regulates NF-kappaB-dependent gene expression. Nat Cell Biol 12: 758-767, 2010.
29. Takai KK, Kibe T, Donigian JR, Frescas D and de Lange T: Telomere protection by TPP1/POT1 requires tethering to TIN2. Mol Cell 18: 647-659, 2011.
30. Tejera AM, Stagno d'Alcontres M, Thanasoula M, et al: TPP1 is required for TERT recruitment, telomere elongation during nuclear reprogramming, and normal skin development in mice. Dev Cell 18: 775-789, 2010.
31. Baumann P and Price C: Pot1 and telomere maintenance. FEBS Lett 10: 3779-3784, 2010.
32. Schoeftner S and Blasco MA: Developmentally regulated tran scription of mammalian telomeres by DNA-dependent RNA polymerase II. Nat Cell Biol 10: 228-236, 2008. (Pubitemid 351194053)
33. Nergadze SG, Farnung BO, Wischnewski H, et al: CpG-island promoters drive transcription of human telomeres. RNA 15: 2186-2194, 2009.
34. De Lange T: Shelterin: the protein complex that shapes and safe guards human telomeres. Genes Dev 19: 2100-2110, 2005.
35. Hsiao SJ and Smith S: Tankyrase function at telomeres, spindle poles and beyond. Biochimie 90: 83-92, 2008. (Pubitemid 350216209)
36. Cook BD, Dynek JN, Chang W, Shostak G and Smith S: Role for the related poly (ADP-Ribose) polymerases tankyrase 1 and 2 at human telomeres. Mol Cell Biol 22: 332-342, 2002. (Pubitemid 33144279)
37. Chen Y, Yang Y, van Overbeek M, Donigian JR, Baciu P, de Lange T and Lei M: A share docking motif in TRF1 and TRF2 used for differential recruitment of telomeric proteins. Science 319: 1092-1096, 2008. (Pubitemid 351300791)
38. Zhou XZ and Lu KP: The Pin2/TRF1-interacting protein PinX1 is a potent telomerase inhibitor. Cell 107: 347-359, 2001. (Pubitemid 33049978)
39. Van Overbeek M and de Lange T: Apollo, an Artemis-related nuclease interacts with TRF2 and protects human telomerase in S phase. Curr Biol 16: 1295-1232, 2006.
40. Bae JB, Mukhopadhyay SS, Liu L, et al: Snm1B/Apollo mediates replication fork collapse and S phase checkpoint activation in response to DNA interstrand cross-links. Oncogene 27: 5045-5056, 2008.
41. Sarthy JF and Baumann P: Apollo-taking the lead in telomere protection. Mol Cell 39: 489-491, 2010.
42. Deng Y, Guo X, Ferguson DO and Chang S: Multiple roles for MRE11 at uncapped telomeres. Nature 460: 914-918, 2009.
43. Lee JH and Paull TT: Activation and regulation of ATM kinase activity in response to DNA double-strand breaks. Oncogene 26: 7741-7748, 2007.
44. Landsverk HB, Mora-Bermúdez F, Landsverk OJ, et al: The protein phosphatase 1 regulator PNUTS is a new component of the DNA damage response. EMBO Rep 11: 868-875, 2010.
45. Mohammad DH and Yaffe MB: 14-3-3 proteins, FHA domains and BRXT domains in the DNA damage response. DNA Repair 8: 1009-1017, 2009.
46. Kipling D and Faragher RG: Progeroid syndromes: probing the molecular basis of aging? Mol Pathol 50: 234-241, 1997. (Pubitemid 27475772)
47. Ozgenc A and Loeb LA: Current advances in unraveling the function of the Werner syndrome protein. Mutat Res 577: 237-251, 2005. (Pubitemid 41225503)
48. Opresko PL, Von Kobbe C, Laine JP, HarriganJ, Hickson ID and Bohr VA: Telomere binding protein TRF2 binds to and stimulates the Werner and Bloom syndrome helicases. J Biol Chem 277: 41110-41119, 2002. (Pubitemid 35215702)
49. Saharia A, Guittat L, Crocker S, Lim A, Steffen M, Kulkarni S and Stewart SA: Flap endonuclease 1 contributes to telomere stability. Curr Biol 18: 496-500, 2008.
50. Saharia A, Teasley DC, Duxin JP, Dao B, Chiappinelli KB and Stewart SA: FEN1 ensures telomere stability by facilitating replication fork re-initiation. J Biol Chem 285: 27057-27066, 2010.
51. Diffley JF and Labib L: The chromosome replication cycle. J Cell Sci: 115: 869-872, 2000. (Pubitemid 34257371)
52. Deng Z, Dheekollu J, Broccoli D, Dutta A and Lieberman PM: The origin recognition complex localizes to telomere repeats and prevents telomeric-circle formation. Curr Biol 17: 1989-1995, 2007. (Pubitemid 350088493)
53. Deng Z, Norseen J, Wiedmer A, Rietman H and Lieberman PM: TERRA RNA binding to TRF2 facilitates heterochromatin formation and ORC recruitment at telomeres. Mol Cell 35: 403-413, 2009.
54. Ciccia A and Elledge SJ: The DNA damage response: making it safe to play with knives. Mol Cell 40: 179-204, 2010.
55. Kibe T, Osawa GA, Keegan CE and de Lange T: Telomere protection by TPP1 is mediated by POT1a and POT1b. Mol Cell Biol 30: 1059-1066, 2010.
56. Bryan TM, Englezou A, Dalla-Pozza L, Dunham MA and Reddel RR: Evidence for an alternative mechanism for main taining telomere length in human tumors and tumor-derived cell lines. Nat Med 3: 1271-1274, 1997. (Pubitemid 27508830)
57. Dunham MA, Neumann AA, Fasching CL and Reddel RR: Telomere maintenance by recombination in human cells. Nat Genet 26: 447-450, 2000.
58. Chen Q, Ijpma A and Greider CW: Two survivor pathways that allow growth in the absence of telomerase are generated by distinct telomere recombination events. Mol Cell Biol 21: 1819-1827, 2001. (Pubitemid 32156401)
59. Huang P, Pryde FE, Lester D, Maddison RL, Borts RH, Hickson ID and Louis EJ: SGS1 is required for telomere elongation in the absence of telomerase. Curr Biol 11: 125-129, 2001. (Pubitemid 32116846)
60. Rizki A and Lundbland V: Defects in mismatch repair promote telomerase-independent proliferation. Nature 411: 713-716, 2001. (Pubitemid 32531679)
61. Harley CB, Futcher AB and Greider CW: Telomeres shorten during ageing of human fibroblasts. Nature 345: 458-460, 1991.
62. Allsoop RC and Harley CB: Evidence for a critical telomeric length in senescent human fibroblasts. Exp Cell Res 219: 130-136, 1995.
63. Campisi J: The biology of replicative senescence. Eur J Cancer 33: 703-709, 1997.
64. Vaziri H and Benchimol S: Reconstitution of telomerase activity in normal human cells lead to elongation of telomeres and extended replicative life span. Curr Biol 8: 279-282, 1998. (Pubitemid 28111458)
65. Chang E and Harley CB: Telomere length and replicative aging in human vascular tissues. Proc Natl Acad Sci USA 92: 11190-11194, 1995.
66. Bodnar AG, Kim NW, Effros RB and Chiu CP: Mechanism of telomerase induction during T cell activation. Exp Cell Res 228: 58-64, 1996. (Pubitemid 26349713)
67. Hastie ND, Dempster M, Dunlop MG, Thompson AM, Green DK and Allshire RC: Telomere reduction in human colorectal carcinoma and with ageing. Nature 346: 866-868, 1990.
68. Counter CM, Avillon AA, LeFeuvre CE, Stewart NG, Greider CW, Harley CB and Bacchetti S: Telomere shortening associated with chromosome instability is arrested in immortal cells witch express telomerase activity. EMBO J 11: 1921-1929, 1992.
69. Dhaeene K, Van Marck E and Parwaresch R: Telomeres, telomerase and cancer: an up-date. Virchows Arch 437: 1-16, 2000. (Pubitemid 30446910)
70. Gauthier LR, Granotier C, Soria JC, Faivre S, Boige V, Raymond E and Boussin FD: Detection of circulating carcinoma cells by telomerase activity. Br J Cancer 84: 631-635, 2001. (Pubitemid 32238996)
71. Soria JC, Gauthier LR, Raymond E, et al: Molecular detection of telomerase positive circulating epithelial cells in metastatic breast cancer patients. Clin Cancer Res 5: 971-975, 1999. (Pubitemid 29233209)
72. Pfitzenmaier J, Ellis WJ, Arfman EW, Hawley S, McLaughlin PO, Lange PH and Vessella RL: Telomerase activity in disseminated prostate cancer cells. BJU Int 97: 1309-1313, 2006. (Pubitemid 43907341)
73. Walne AJ and Dokal I: Dyskeratosis Congenita: a historical perspective. Mech Ageing Dev 129: 48-59, 2008. (Pubitemid 351199862)
74. Vulliamy T, Marrone A, Dokal I and Mason PJ: Association between aplastic anaemia and mutations in telomerase RNA. Lancet 22: 2168-2170, 2002. (Pubitemid 34694028)
75. Nishio N and Kojima S: Recent progress in dyskeratosis congenita. Int J Hematol 92: 419-424, 2010.
76. Armanios M: Telomerase and idiopathic pulmonary fibrosis. Mutat Res 730: 52-58, 2012.
77. Armanios M: Syndromes of telomere shortening. Annu Rev Genomics Hum Genet 10: 45-61, 2009.
78. Fu D and Collins K: Purification of human telomerase complexes identifies factors involved in telomerase biogenesis and telomere length regulation. Mol Cell 28: 773-785, 2007. (Pubitemid 350217053)
79. Veinteicher AS, Meng Z, Mason PJ, Veenstra TD and Artandi SE: Identification of ATPases pontin and reptin as telomerase compo nents essential for holenzyme activity. Cell 132: 945-957, 2008. (Pubitemid 351381739)
80. Zhong F, Savage SA, Shkreli M, et al: Disruption of telomerase trafficking by TCAB1 mutation causes dyskeratosis congenita. Genes Dev 25: 11-16, 2011.
81. Cohen SB, Graham ME, Lovrecz GO, Bache N, Robinson PJ and Red del RR: Protein composition of catalytically active human telomerase from immortal cells. Science 30: 1850-1853, 2007.
82. Bryce LA, Morrison N, Hoare SF, Muir S and Keith WN: Mapping of the gene for the human telomerase reverse transcrip tase, hTERT, to chromosome 5p15.33 by fluorescence in situ hybridization. Neoplasia 2: 197-201, 2000. (Pubitemid 30346075)
83. Kyo S, Takakura M, Fujiwara T and Inoue M: Understanding and exploiting hTERT promoter regulation for diagnosis and treatment of human cancers. Cancer Sci 99: 1528-1538, 2008.
84. Blasco MA, Funk W, Villeponteau B and Greider CW: Functional characterization and developmental regulation of mouse telom erase RNA. Science 269: 1267-1270, 1996.
85. Cairney CJ and Keith WN: Telomerase redefined: integrated regulation of hTR and hTERT for telomere maintenance and telomerase activity. Biochimie 90: 13-23, 2008. (Pubitemid 350216212)
86. Tsao DA, Wu CW and Lin YS: Molecular cloning of bovine telomerase RNA. Gene 221: 51-58, 1998.
87. Morin GB: The human telomere terminal transferase enzyme is a ribonucleoprotein that synthesizes TTAGGG repeats. Cell 59: 521-529, 1989.
88. Chen JL, Blasco MA and Greider CW: Secondary structure of vertebrate telomerase RNA. Cell 100: 503-514, 2000.
89. Theimer CA and Feigon J: Structure and function of telomerase RNA. Curr Opin Struct Biol 16: 307-318, 2006. (Pubitemid 43831650)
90. Park JI, Venteicher AS, Hong JY, et al: Telomerase modulates Wnt signaling by association with target gene chromatin. Nature 460: 66-72, 2009.
91. Maida Y, Yasukawa M, Furuuchi M, et al: RNA-dependent RNA polymerase formed by TERT and the RMRP RNA. Nature 4610: 230-235, 2009.
92. Cong Y and Shay JW: Actions of human telomerase beyond telomeres. Cell Res 18: 725-732, 2008. (Pubitemid 351948231)
93. Santos JH, Meyer JN, Skorvaga M, Annab LA and Van Houten B: Mitochondrial hTERT exacerbates free-radical-mediated mtDNA damage. Aging Cell 6: 399-411, 2004. (Pubitemid 40246710)
94. Santos JH, Meyer JN and Van Houten B: Mitochondrial localiza tion of telomerase as a determinant for hydrogen peroxide-induced mitochondrial DNA damage and apoptosis. Hum Mol Genet 15: 1757-1768, 2006. (Pubitemid 43821766)
95. Tárkány I and Aradi J: Pharmacological intervention strategies for affecting telomerase activity: Future prospects to treat cancer and degenerative disease. Biochimie 90: 156-172, 2008.